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Abstract
Background: Coat colours in canines have many natural phenotypic variants. Some of the genes
and alleles involved also cause genetic developmental defects, which are also observed in humans
and mice. We studied the genetic bases of the merle phenotype in dogs to shed light on the
pigmentation mechanisms and to identify genes involved in these complex pathways. The merle
phenotype includes a lack of eumelanic pigmentation and developmental defects, hearing
impairments and microphthalmia. It is similar to that observed in microphthalmia mouse mutants.
Results: Taking advantage of the dog as a powerful genetic model and using recently available
genomic resources, we investigated the segregation of the merle phenotype in a five-generation
pedigree, comprising 96 sampled Australian shepherd dogs. Genetic linkage analysis allowed us to
identify a locus for the merle phenotype, spanning 5.5 megabases, at the centromeric tip of canine
chromosome 10 (CFA10). This locus was supported by a Lod score of 15.65 at a recombination
fraction θ = 0. Linkage analysis in three other breeds revealed that the same region is linked to the
merle phenotype. This region, which is orthologous to human chromosome 12 (HSA12 q13-q14),
belongs to a conserved ordered segment in the human and mouse genome and comprises several
genes potentially involved in pigmentation and development.
Conclusion: This study has identified the locus for the merle coat colour in dogs to be at the
centromeric end of CFA10. Genetic studies on other breeds segregating the merle phenotype
should allow the locus to be defined more accurately with the aim of identifying the gene. This work
shows the power of the canine system to search for the genetic bases of mammalian pigmentation
and developmental pathways.
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Background
Coat colours in mammals depend on skin and hair pig-
ment synthesis. Melanocytes manufacture two types of
melanin: the black/brown photo-protective eumelanin
pigment, and the red-yellow cytotoxic phaeomelanin pig-
ment. Several paracrine factors secreted primarily by sur-
rounding keratinocytes are involved in the melanogenic
pathway by stimulating the switch between phaeomela-
nin and eumelanin [1]. In this pathway, microphthalmia
transcription factor (MITF) plays a central role by regulating
the expression of the TYR  (Tyrosinase), TRP-1 (Tyrosine
Related Protein) and DCT (Dopachrome Tautomerase) genes
that encode enzymes involved in pigment manufacture
[2,3].
Coat colour is highly polymorphic in dogs. In 1957, Little
described, after observing the possible phenotypes, more
than 20 loci affecting coat colours [4,5]. Until recently,
only a few genes were recognised as involved in pigmen-
tation. However, more and more genes, alleles and new
interactions are being discovered: variants of melanocortine
1 receptor gene (MC1R), (locus previously called extension
E) [6-8], variants of Agouti, the antagonist ligand of MC1R
[9,10], variants of tyrosinase-related protein 1 (TYRP1) [11]
and variants of melanophillin  [12]. Three mutations
responsible for the brown coat colour versus black coat
colour were described in TYRP1  in several dog breeds
including the Australian Shepherd dog [11]. Genomic
tools are now fully available in canine genetics: dense
radiation hybrid maps with 1500 polymorphic microsat-
ellite markers and anchored BAC markers [13,14], a radi-
ation hybrid map comprising 10,000 canine gene-based
markers [15], and a whole sequence assembly of the
canine genome, build 2.1 [16]. Altogether, the dog
appears to be a good model for understanding better the
genetics of pigmentation in mammals and for isolating
new genes, new variants and interactions between alleles
of different loci.
We are interested in the merle phenotype because of its
involvement in coat colour and developmental impair-
ments. The merle phenotype is a dominant trait, with het-
erozygous dogs presenting a coat colour in which
eumelanic regions are incompletely and irregularly
diluted, leaving intensely pigmented patches. Merle  is
found throughout the body except on the pheomelanic
regions of the black and tan coat colour (Figure 1A, 1B).
These dogs often have heterochromia iridis or blue eyes
and often have a lack of retinal pigment visible on the fun-
dus. Homozygous merle dogs display a more severe phe-
notype. The dogs are usually very pale, sometimes
completely white and present developmental defects with
an incomplete penetrance, microphthalmia and hearing
loss (Figure 1C, 1D). In merle European lineages, micro-
phthalmia and/or hearing loss are not frequently
observed as breeders avoid mating merle dogs to avoid
these developmental defects. However, several veterinary
studies on the "merle syndrome", reported retinal defects
[17], microphthalmia and coloboma [18]. The non-sur-
vival or degeneration of melanocytes in the cochlea have
been suggested to explain hearing loss [19].
When analysing the genetic basis of the merle phenotype,
Little suggested that a unique locus (called M) was respon-
sible for the merle phenotype in different breeds [4]. It was
proposed that the merle coat colour may be due to a trans-
posable element, after the observation of two germinal
reversions out of 66 merle  offspring of a homozygous
merle female [20]. Recently, the Kit Ligand, KITLG, was
excluded as a candidate gene for the merle phenotype in
dogs [21] and the candidate gene approach has not yet
give any conclusive results.
We searched for candidate genes for the merle phenotype
in dogs by considering well-described pigment disorders
in mice. Mutations in the gene of the Mitf pathway cause
specific coat colour phenotypes, some of which are simi-
lar to the merle phenotype in dogs. These include dilution
of the coat colour in patches and complete or mild micro-
phthalmia (Figure 1E, 1F). Also, the complete abolition of
functional Mitf results in loss of the melanocyte lineage,
causing a white coat colour due to a lack of pigment cell
manufacturer, and additional eye (microphthalmia) and
inner ear disorders. Heteroallelic combinations of MITF
variants produce animals with normal sized dark eyes and
yellowish-brown to grey spotted checker board-like coat
colours [22,23]. Mitf is also involved in human Waarden-
burg syndromes, including pigment cell migration disor-
ders [24] and developmental defects such as deafness.
Pax3 (Paired box gene 3) and Sox10 (SRY – Sex determin-
ing region Y-box 10), which regulates MITF gene expres-
sion, are also associated with this syndrome [25,26]. This
genetic evidence suggest that MITF, PAX3 and  SOX10
genes may be candidate genes for the merle phenotype.
We collected a pedigree of Australian shepherd dogs and
used a genetic linkage approach with microsatellite mark-
ers flanking the MITF, PAX3 and SOX10 candidate genes
to search for the genetic bases of the merle coat colour in
canines. Although these three genes were excluded for the
merle phenotype in dogs, we successfully identified the
merle locus on canine chromosome 10, close to the cen-
tromere, 20 Mb away from Sox10. This locus was
restricted to a 5.5 Mb interval and was further confirmed
by analysing families of other breeds segregating the merle
phenotype.BMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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Results
Pedigrees
A pedigree comprising 96 Australian shepherd dogs (43
brown and 53 black dogs) was collected. This pedigree,
called the "complete pedigree", included 42 merle dogs. A
sub-pedigree of 38 dogs, including 17 merle dogs, derived
from the complete pedigree was used for genotyping (Fig-
ure 2). Isolated families from different breeds segregating
the merle coat colour were also collected, including three
dachshund families (14 dogs); a Beauce shepherd family
(five dogs) and a Border collie family (13 dogs).
Genetic linkage analysis of the brown coat colour in the 
pedigrees
We evaluated the linkage power of the pedigrees by inves-
tigating the genetic linkage between the brown phenotype
and the TYRP1  gene in the complete pedigree. As the
TYRP1  gene was previously associated with the brown
coat colour in dogs [11], we genotyped markers linked to
TYRP1. These markers, FH2319 and REN105I03, are 1.18
and 5.17 Mb from TYRP1, respectively (see Additional file
1). The Lod scores between the brown phenotype and
FH2319 and REN105I03 markers obtained by a two-point
analysis on the complete pedigree, were 7.2 and 3.5
respectively, with a recombination fraction of θ = 0. For
the sub-pedigree, the Lod scores were 3.6 and 2.4 respec-
tively at θ = 0. The number of informative meiosis for the
brown phenotype was 58 in the complete pedigree and 16
in the sub-pedigree. As the number of informative meiosis
for the merle phenotype significantly increased to 81 and
33 in the complete pedigree and sub-pedigree, respec-
tively, we expected these present pedigrees to be valuable
for linkage analysis of the merle phenotype.
Genetic linkage analysis of the merle trait
As expected, the transmission mode in the collected pedi-
grees was consistent with an autosomal dominant segre-
gation of the merle phenotype.
Using the sub-pedigree, we carried out genetic linkage
analysis on polymorphic markers either flanking or
within the intronic part of TYRP1 gene and the candidate
genes  MITF,  PAX3, and SOX 10. Two-point analysis
showed no significant linkage between the merle pheno-
type and markers flanking the MITF  and  PAX3  genes
(Table 1). Therefore, we could exclude MITF and PAX3
being involved in this phenotype. However, we found sig-
nificant linkages (Lod scores ranging from 3.09 to 3.65)
with markers flanking SOX10, with recombination frac-
tions, θ, ranging from 0.08 to 0.14 (Table 2). This sug-
Pictures of none merle and merle dogs and mice microphthalmia mutants Figure 1
Pictures of none merle and merle dogs and mice microphthalmia mutants. A: Black and tan Australian Shepherd dog. 
B: Heterozygous merle Australian shepherd dog (pictures from Elevage du Paradis Sauvage de Ménestruel, Poncin, France) [40]. 
C: Six-month homozygous merle collie: the coat colour is totally white and the dog is blind and deaf. D: The left eye of the 
same dog, shows a microphthalmia with microcornea and a cataract (pictures from Dr Gilles Chaudieu, DVM, Dip. ECVO, 
Chamalières, France). E: Mitfmi-sp/Mitfmi-vga9 mouse. F: Mitfmi-vga9/Mitfmi-vga9 mouse with severe microphthalmia (pictures from Ste-
ingrímsson [23]).BMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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gested that the merle locus was about 10 cM from SOX10.
As part of a "chromosome walking strategy", we selected
30 new polymorphic markers spanning a 27 Mb region
from the SOX10 region to the centromeric tip of CFA10,
as the C10.769 marker telomeric to SOX10 had a decreas-
ing Lod score (Table 2).
Linkage analysis allowed us to identify seven markers
close to the centromere, CFA10.1 to CFA10.8, which
cosegregate with the merle phenotype with significant Lod
scores (> 3) (Table 2, see Additional file 2).
We extended the genetic linkage by analysing the nine
most centromeric markers in the "complete pedigree" and
in three nuclear families of dachshund, Beauce shepherd
and Border collie segregating the merle  phenotype. We
obtained increased Lod scores for markers CFA10.1 to
CFA10.8, with maximum Lod scores for CFA10.7 and
CFA10.8 (Lod scores at θ = 0 of 15.65 and 14.90 in the
complete pedigree and 19.87 and 19.57 in the complete
pedigree plus the three other families, respectively). The
CFA10.9 marker (telomeric to CFA10.8) is unlinked to the
phenotype (Lod scores at θ = 0 of -14.38 in the complete
pedigree and -11.97 in the complete pedigree plus the
three other families, respectively, Table 2). Haplotype
analyses of this region allowed us to detect a recombina-
tion event between the merle phenotype and the CFA10.9
microsatellite, thus limiting further the merle locus (Figure
3). These data, as well as the previous results for SOX10
flanking markers (Table 2), allowed us to exclude the
SOX10 gene as being involved in the merle phenotype.
Our results show that the merle locus is located in a 5.5 Mb
region between the end of the centromere, arbitrarily
located at 3 Mb, (represented by CFA10.1 located at 3.1
Mb) and the CFA10.9 marker (located at 8.5 Mb) defining
the telomeric limit of the critical interval (see Additional
file 2).
Discussion
In the present study, we used a genetic linkage approach
on a pedigree of Australian shepherd dogs segregating the
merle phenotype. We identified with high statistical sup-
port a 5.5 Mb locus at the centromeric tip of CFA10 in
which the gene responsible for this phenotype should be
found. Dog samples were collected from breeders. As phe-
notyping was easily and immediately detectable after
birth by breeders themselves and then officially declared
to the breed club, we have been able to obtain an inform-
ative family with as many as five generations of Australian
shepherd dogs. Moreover, parentage testing ensured good
Sub-pedigree of 38 sampled Australian shepherd dogs (19 brown and 19 black dogs) Figure 2
Sub-pedigree of 38 sampled Australian shepherd dogs (19 brown and 19 black dogs).BMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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reliability of the pedigrees. Such collected pedigrees from
existing families means that housing of dogs is not
required, limiting housing costs and ethical issues.
We focused on three candidate genes belonging to the
coat colour pathway: MITF, PAX3 and SOX 10. The merle
phenotype shares similarities with Mitf mouse mutants in
coat colour and ocular and hearing defects, and also with
human Waardenburg patients. However, our genetic link-
age study ruled out these three genes as being involved in
the merle phenotype. Genetic analysis of the SOX10 region
in the sub-pedigree, using a "chromosome walking" strat-
egy on CFA10, allowed us to identify the merle locus. It
spans a 5.5 Mb region 20 Mb away from SOX10. Genetic
linkage analyses on the complete pedigree and on small
families from other breeds confirmed that the merle locus
was located between the CFA10 centromere (3 Mb) and
the CFA10.9 marker (8.5 Mb), with the highest Lod score
of 19.87.
The corresponding orthologous human region is
HSA12q13-q14 (position from 54.36 Mb to 60.94 Mb)
and mouse region is MMU10D3 (position from 122.8 Mb
to 128.7 Mb). These orthologous dog, human and mouse
regions correspond to a unique conserved ordered seg-
ment, which has the same orientation in dogs and
humans but is inverted between dogs and mice. In the dog
region, 99 genes are predicted and 48 are known
(Broad1), in the human region, 134 genes are predicted
and 98 are known (NCBI 35), and in the mouse region,
112 genes are predicted and 95 are known (NCBI M34)
[27]. These gene numbers may vary due to slight changes
in the annotated genes as the versions are updated. In
humans, mice and dogs, the conserved segments are
totally ordered, making annotation of the dog segment
easy, thus helping determination of candidate merle
genes. This locus has many candidate genes, with at least
a dozen being potential metabolic candidates as they, or
their paralogs, belong to the pigmentation pathway. These
include proteins involved in neural crest development
(such as ERBB3), melanosome motility and transfer to
surrounding keratinocytes (such as Silv/Pmel-17 and rab,
kinesin, dynactin, myosin proteins).
Although the MITF  gene itself has been excluded, the
merle mutation should affect a gene interacting directly
with the MITF gene in the pigmentation pathway. Alterna-
tively, a more complex mechanism could explain the
incomplete penetrance of eye defects observed in
homozygous merle dogs. Although hearing loss may be
due to an extreme white phenotype, including the absence
of melanocytes in the cochlea, as in other white canine
breeds [28], less is known about the origins of microph-
thalmia and other ocular defects. These may be due to
another mutation in the same locus.
The merle phenotype occurs in several breeds and is com-
monly encountered in mongrel dogs. Breeds segregating
Table 1: Linkage data between the merle phenotype and markers flanking the TYRP1 gene and MITF and PAX3 candidate genes. Two 
point Lod scores and recombination fractions (θ) between the merle phenotype and the markers flanking TYRP1, MITF and PAX3 genes 
calculated on the sub-pedigree. a CFA: Canis familiaris chromosome. b Starred markers were selected from the CanFam 1.0 canine 
sequence draft. Significant exclusions (<-2) are indicated in bold.
θ at Lod score max Lod scores at θ
CFAa Gene/Markersb Gene/Marker
Position in bp
θ Lod score max 0.001 0.01 0.05 0.1 0.15 0.2 0.3
CFA11 TYRP1 34,664779–34,683148
FH2319 35,863893–35,864169 0.5 0.0 -23.083 -13.146 -6.442 -3.802 -2.429 -1.582 -0.661
Ren105l03 39,857761–39,857999 0.5 0.0 -15.888 -8.939 -4.278 -2.471 -1.549 -0.995 -0.417
Ren96j16 22,981531–22,981669 0.5 0.0 -13.194 -8.198 -4.721 -3.24 -2.384 -1.786 -0.963
Ren130E03 22,981511–22,981683 0.5 0.0 -13.194 -8.198 -4.721 -3.24 -2.384 -1.786 -0.963
Ren159M20 23,456266–23,456464 0.5 0.0 -19.789 -11.82 -6.37 -4.141 -2.915 -2.1 -1.061
CFA20 MITF 24,701418–24,735483
Ren100j13 25,668407–25,668570 0.5 0.0 -24.585 -14.621 -7.791 -4.988 -3.442 -2.417 -1.131
Ren178E07 26,911251–26,911383 0.5 0.0 -12.593 -7.605 -4.164 -2.729 -1.923 -1.377 -0.671
Ren105M20 19,606338–19,606486 0.4 0.087 -8.992 -5.016 -2.327 -1.264 -0.709 -0.367 -0.011
Ren67C18 22,361131–22,361265 0.5 0.0 -11.992 -7.012 -3.606 -2.218 -1.462 -0.969 -0.379
Pax3.2* 30,185679–30,186031 0.27 0.147 -9.89 -4.957 -1.763 -0.644 -0.159 0.063 0.137
CFA37 PAX3 31,332182–31,429995
Pax3.1* 31,368786–31,369020 0.5 0.0 -20.085 -11.159 -5.204 -2.924 -1.779 -1.101 -0.418
Ren75L05 31,649572–31,649607 0.5 0.0 -9.294 -5.321 -2.65 -1.605 -1.065 -0.732 -0.36BMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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Table 2: Linkage data between the merle phenotype and CFA10 markers. List of the CFA10 genotyped markers in the sub-pedigree 
(left), the complete pedigree (middle) and all the studied pedigrees (right), with their two point Lod scores and recombination 
fractions (θ). All markers were selected from CanFam 1.0 sequence draft except FH2293 and C10769 taken from Guyon et al.[13]. 
The markers are ordered in the table from the centromere to the telomere. a markers flanking the SOX10 gene. Values in bold 
correspond to the highest Lod scores obtained in the three conditions.
Two point Lod scores values
θ at Lod max Lod scores at θ
Gene/Marker names Marker Position (in bp) θ Lod max 0.001 0.01 0.05 0.1 0.15 0.2 0.3
Lod scores in the 
sub-pedigree
CFA10.1 3,109459–3,109703 0.00 6.32 6.31 6.22 5.79 5.23 4.64 4.02 2.68
CFA10.2 3,150322–3,150695 0.00 6.92 6.91 6.82 6.37 5.78 5.16 4.50 3.05
CFA10.3 3,169429–3,169640 0.00 3.01 3.01 2.95 2.72 2.42 2.10 1.76 1.06
CFA10.4 3,452451–3,452757 0.04 5.94 4.82 5.71 5.90 5.55 5.04 4.44 3.04
CFA10.5 c 3,533969–3,534312 0.00 6.92 6.91 6.81 6.35 5.73 5.09 4.40 2.90
CFA10.6 4,050670–4,050915 0.00 3.01 3.01 2.96 2.74 2.46 2.17 1.86 1.20
CFA10.7 4,901919–4,902276 0.00 7.23 7.21 7.11 6.65 6.04 5.39 4.71 3.20
CFA10.8 6,938580–6,938928 0.00 7.23 7.21 7.11 6.65 6.04 5.39 4.71 3.20
CFA10.9 8,539383–8,539710 0.50 0.00 -20.08 -11.15 -5.16 -2.85 -1.68 -0.98 -0.31
CFA10.10 9,459108–9,459324 0.07 2.62 1.21 2.15 2.60 2.57 2.40 2.16 1.52
CFA10.11 10,599594–10,599989 0.04 5.08 3.91 4.82 5.07 4.79 4.35 3.84 2.64
CFA10.12 12,963916–12,964094 0.15 2.55 -4.49 -0.58 1.79 2.43 2.55 2.44 1.83
CFA10.13 13,290922–13,291305 0.18 0.75 -2.99 -1.03 0.21 0.60 0.73 0.74 0.57
CFA10.14 13,687824–13,688059 0.11 3.44 -1.49 1.42 3.09 3.43 3.36 3.10 2.25
CFA10.15 15,287513–15,287805 0.14 2.22 -2.99 -0.06 1.69 2.15 2.21 2.08 1.51
CFA10.16 16,325750–16,325992 0.09 3.67 0.61 2.53 3.55 3.66 3.49 3.19 2.33
CFA10.17 16,883188–16,883575 0.12 2.95 -2.09 0.83 2.53 2.92 2.91 2.72 2.02
CFA10.18 17,574178–17,574420 0.08 3.87 0.91 2.82 3.79 3.84 3.61 3.25 2.31
CFA10.19 18,220318–18,220600 0.10 4.20 -0.58 2.31 3.93 4.20 4.07 3.74 2.75
CFA10.20 19,075239–19,075433 0.12 3.19 -1.79 1.12 2.81 3.17 3.13 2.90 2.10
CFA10.21 19,999011–19,999231 0.26 0.51 -11.69 -5.76 -1.88 -0.50 0.12 0.41 0.47
CFA10.22 21,607022–21,607316 0.10 4.45 -0.28 2.61 4.20 4.45 4.30 3.95 2.90
CFA10.23 21,956041–21,956337 0.10 4.45 -0.28 2.61 4.20 4.45 4.30 3.95 2.90
CFA10.24 23,113457–23,113656 0.25 0.92 -13.18 -6.27 -1.77 -0.17 0.52 0.83 0.85
CFA10.25 24,031569–24,031859 0.10 3.51 -1.19 1.70 3.28 3.51 3.34 2.97 1.93
CFA10.26 25,504535–25,504764 0.14 2.73 -4.19 -0.29 2.05 2.65 2.73 2.57 1.89
CFA10.27 25,930447–25,930692 0.12 1.84 -1.49 0.45 1.58 1.83 1.81 1.67 1.16
CFA10.28 26,491052–26,491288 0.13 1.66 -1.79 0.16 1.32 1.62 1.65 1.56 1.16
CFA10.29 27,391154–27,391817 0.18 2.36 -6.88 -1.98 1.09 2.04 2.33 2.33 1.87
CFA10.30 28,230039–28,230419 0.30 0.69 -18.28 -9.37 -3.47 -1.27 -0.23 0.33 0.69
CFA10.31a 29,232270–29,232511 0.13 3.51 -3.28 0.61 2.90 3.46 3.49 3.27 2.45
CFA10.32a 29,355913–29,355989 0.14 3.09 -3.88 0.02 2.37 2.99 3.08 2.94 2.24
CFA10.33a 29,483066–29,483109 0.13 2.40 -2.69 0.23 1.95 2.37 2.38 2.22 1.58
CFA10.34a 29,826073–29,826290 0.14 2.52 -2.69 0.24 2.00 2.45 2.51 2.38 1.81
CFA10.35a 29,834441–29,834690 0.16 2.74 -6.28 -1.39 1.63 2.51 2.73 2.67 2.08
SOX10 29,856920–29,867728
CFA10.36a 29,861299–29,861547 0.08 3.60 0.61 2.52 3.51 3.58 3.37 3.02 2.10
CFA10.37a 29,868038–29,868267 0.14 3.38 -3.58 0.32 2.67 3.29 3.37 3.21 2.47
CFA10.38a 30,176995–30,177378 0.11 3.65 -1.19 1.71 3.35 3.65 3.55 3.26 2.38
FH2293a 31,696028–31,696274 0.13 3.56 -3.28 0.61 2.93 3.50 3.54 3.34 2.53
C10.769a 36,663349–36,663563 0.18 1.50 -5.99 -2.06 0.42 1.20 1.46 1.49 1.18
Lod scores in the 
complete pedigree
CFA10.1 3,109459–3,109703 0.00 11.74 11.72 11.54 10.70 9.61 8.46 7.27 4.71
CFA10.2 3,150322–3,150695 0.02 11.97 11.13 11.91 11.63 10.64 9.48 8.20 5.38
CFA10.3 3,169429–3,169640 0.00 6.62 6.61 6.50 5.98 5.30 4.60 3.86 2.33
CFA10.4 3,452451–3,452757 0.03 13.82 11.73 13.46 13.65 12.67 11.36 9.88 6.55
CFA10.5 c 3,533969–3,534312 0.02 8.77 7.82 8.65 8.58 7.88 7.01 6.03 3.86
CFA10.6 4,050670–4,050915 0.00 6.92 6.91 6.79 6.24 5.51 4.76 3.99 2.41
CFA10.7 4,901919–4,902276 0.00 15.65 15.63 15.39 14.30 12.88 11.40 9.84 6.54
CFA10.8 6,938580–6,938928 0.02 14.90 14.13 14.87 14.39 13.16 11.72 10.17 6.76BMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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CFA10.9 8,539383–8,539710 0.19 2.48 -14.38 -5.54 0.02 1.78 2.38 2.47 1.89
Lod scores in the 
complete pedigree 
plus families
 of dachshund, 
Beauce shepherd 
and Border collie
CFA10.1 3,109459–3,109703 0.04 10.67 8.43 10.21 10.61 9.91 8.91 7.74 5.09
CFA10.2 3,150322–3,150695 0.04 10.97 8.73 10.51 10.91 10.21 9.21 8.04 5.39
CFA10.3 3,169429–3,169640 0.00 6.02 6.01 5.91 5.44 4.84 4.22 3.56 2.20
CFA10.4 3,452451–3,452757 0.03 14.38 12.33 14.05 14.19 13.15 11.79 10.25 6.83
CFA10.5 c 3,533969–3,534312 0.02 8.77 7.82 8.65 8.58 7.89 7.02 6.05 3.90
CFA10.6 4,050670–4,050915 0.03 6.99 6.01 6.86 6.85 6.23 5.46 4.61 2.82
CFA10.7 4,901919–4,902276 0.00 19.87 19.83 19.52 18.11 16.28 14.37 12.37 8.15
CFA10.8 6,938580–6,938928 0.00 19.57 19.53 19.22 17.82 15.99 14.08 12.09 7.91
CFA10.9 8,539383–8,539710 0.16 4.23 -11.97 -3.16 2.25 3.83 4.22 4.10 3.02
Table 2: Linkage data between the merle phenotype and CFA10 markers. List of the CFA10 genotyped markers in the sub-pedigree 
(left), the complete pedigree (middle) and all the studied pedigrees (right), with their two point Lod scores and recombination 
fractions (θ). All markers were selected from CanFam 1.0 sequence draft except FH2293 and C10769 taken from Guyon et al.[13]. 
The markers are ordered in the table from the centromere to the telomere. a markers flanking the SOX10 gene. Values in bold 
correspond to the highest Lod scores obtained in the three conditions. (Continued)
merle are from the collie lineage (Group 1-FCI – Federa-
tion Cynologique Internationale classification): Shetland
sheepdog, Border collie, collie, Australian shepherd dog,
etc., and from other unrelated breeds belonging to differ-
ent FCI groups and different clusters, as defined by Parker
et al. [29], such as dachshund (Group 4-FCI):, Beauce
shepherd (Group 1-FCI), great Dane (Group 2-FCI),
Welsh corgi cardigan and Pyrenean shepherd. The merle
phenotype is most probably very old, with the merle coat
colour being reported in old books [30,31], from which
drawings of merle dogs have been selected and reproduced
[32].
It is not yet known whether the genetic cause of the merle
phenotype is the same in all breeds and mongrels segre-
gating this phenotype. A unique locus has been suggested
as responsible for the merle coat colour [4]. In the present
study, the increased Lod scores observed for genotyped
markers from the merle locus in dachshund, Beauce shep-
herd and Border collie families is consistent, at least in
these breeds, with there being a unique locus for the merle
coat colour. If all merle dogs share a common ancestor
chromosome, all breeds segregating merle could be used
to refine the locus. The sharing of the merle locus by sev-
eral breeds and also by mongrels may be due either to a
common ancestor chromosome region being transmitted
throughout canine evolution and/or to backcrosses that
introduced a merle haplotype in several breeds at different
times.
Conclusion
Using genetic linkage analysis, we excluded the involve-
ment of the MITF, PAX3 and SOX 10 candidates genes in
the merle  phenotype. However, we identified the merle
locus at the centromeric end of CFA10 in pedigrees of Aus-
tralian shepherd dogs, dachshund, Beauce shepherd dogs
and Border collies segregating the merle phenotype. This
locus spans 5.5 Mb and is linked to the merle coat colour
with a maximum Lod score of 19.87 and a recombination
fraction of 0. We are currently analysing this locus in sev-
eral breeds segregating merle, with a high density of single
nucleotide polymorphic markers (SNP). This should help
in identifying the merle gene. As well as benefiting breed-
ing practices and canine veterinary medicine, identifying
the merle gene will also help in understanding the genetic
bases of mammalian pigmentation and developmental
pathways.
Methods
Genomic DNA extraction
No dogs were housed for research purposes, and all dogs
were privately owned pets.
Blood samples and the accompanying pedigree and coat
colour data (with pictures when possible) were collected
by DVM veterinarians. All data were entered into a data-
base. Genomic DNA was extracted from 5 ml of blood col-
lected on EDTA, using the nucleon BACC 3 kit
(Amersham Biosciences, Piscataway, NJ, USA). For low
concentration samples, the extracted DNA was "whole
genome amplified" using the genomiphi kit (Amersham
Biosciences).
Canine pedigree
Pedigrees were constructed using the Cyrillic software
(Cyrillic2.1) [33], which allows haplotypes from the gen-
otyping data to be drawn and the data to be exported in
different formats for use in genetic linkage analysis. We
carried out genotyping of 20 polymorphic microsatellites
from four different chromosomes (CFA10, 11, 20 and 37)
to check and validate the parentage compatibility.
Markers selection and Genotyping experiments
Microsatellite markers were selected from RH map data
[13,34] or from the CanFam 1.0 draft of the canine
genome sequence [35]. Markers were selected from theirBMC Veterinary Research 2006, 2:9 http://www.biomedcentral.com/1746-6148/2/9
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position and their polymorphism level (see Additional
file 1). We used Primer3 software to design PCR primers
[36].
Microsatellite markers were labelled using a two-step-PCR
fluorescent labelling procedure [37]. The first step was car-
ried out on 50 ng of dog genomic DNA using a classical
PCR protocol and a touchdown program of 61°C to
51°C. The second step consisted of a one strand labelling
PCR as previously described [37]. The PCR products were
purified using Sephadex G50 fine column filtration in a
96 format (Amersham Biosciences). An aliquot of 3 μl flu-
orescent purified PCR product was mixed with 0.3 μl (0.2
nM) of fluorescent geneScan-500 ROX size standard
(Applied Biosystems) and 8.7 μl of formamide, and then
loaded onto a 3130 XL genetic analyser (Applied Biosys-
tems). Results were analysed using GeneMapper software
v3.7 (Applied Biosystems) and the genotyping data were
used by Cyrillic software for the genetic linkage analysis.
Genetic linkage analysis
Haplotypes were constructed using the Cyrillic software.
Two-point linkage analysis was carried out between each
marker and the merle phenotype using M-LINK software
through the GLUE web interface [38] and MultiMap soft-
ware [39]. We used the 'prepare' option of CRI-MAP to
check for Mendelian segregation. The linkage between
each pair of markers was carried out with the TWOPOINT
option of CRI-MAP. Lod scores were calculated assuming
an autosomal dominant transmission with full pene-
trance and affected individuals were scored as hetero-
zygous at the phenotype locus.
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